FOXM1 is a transcription factor that is expressed and activated during active cell cycle progression,12 further underscoring a potential role in tumor progression, and FOXM1 has been implicated in the chemoresistance of other types of cancer.13, 14 We thus set out to study whether FOXM1 could be a suitable target of intervention against melanoma. The gene discussed is FOXM1; the disease is cancer.